A Study to Demonstrate the Efficacy and Tolerability of Ferrous Bisglycinate Chelate in Iron Deficiency Anaemia and to Compare These With Those of Ferrous Ascorbate.

NCT01160198 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

271

Enrollment

INDUSTRY

Sponsor class

Conditions

Haematopoiesis

Interventions

DRUG: ferrous ascorbate
DIETARY_SUPPLEMENT: ferrous bisglycinate chelate 1 OD
DIETARY_SUPPLEMENT: ferrous bisglycinate chelate 2 OD

Sponsor

GlaxoSmithKline